Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale SVP, Chief Medical Officer sold 1,042 shares at $2.83 ($2,949)
  5. 4 Open-market sale Director sold 4,567 shares at $3.32 ($15,163)
  6. 4 Grant or award Director acquired 13,700 shares (grant or award)
  7. 4 Grant or award Director acquired 13,700 shares (grant or award)
  8. 4 Grant or award Director acquired 13,700 shares (grant or award)
  9. 4 Grant or award Director acquired 13,700 shares (grant or award)
  10. 4 Grant or award Director acquired 13,700 shares (grant or award)
  11. 4 Grant or award Director acquired 13,700 shares (grant or award)
  12. 4 Open-market sale SVP, CCO sold 952 shares at $3.40 ($3,237)
  13. 4 Open-market sale SVP, CFO and Treasurer sold 790 shares at $3.40 ($2,686)
  14. 4 Open-market sale SVP, Chief Legal Officer sold 1,060 shares at $3.40 ($3,604)
  15. 4 Open-market sale SVP, Chief Operating Officer sold 1,211 shares at $3.40 ($4,117)
  16. 4 Open-market sale CEO and President sold 4,109 shares at $3.40 ($13,971)
  17. 4 Open-market sale SVP, Chief Medical Officer sold 1,081 shares at $3.40 ($3,675)
  18. 4 Grant or award SVP, CFO and Treasurer acquired 7,592 shares (grant or award)
  19. 4 Grant or award CCO acquired 9,152 shares (grant or award)
  20. 4 Grant or award SVP, Chief Legal Officer acquired 10,192 shares (grant or award)

Page 7 of 19 · 378 filings